Technology aims to solve patient competence and adherence challenges, minimizing burden on health care providers and payers.nResearch shows that an estimated 334 million people have asthma worldwide, and 65 million people have moderate to severe COPD — a number that is expected to rise 24% by the year 2034 to make COPD the world’s third leading cause of death. As cases increase, driven by the ageing population, hospitals and care providers continue to see low levels of adherence and poor and inconsistent competence using current treatment devices. This has led to sub-optimal outcomes and higher rates of hospital admissions. Answering the need for a solution to device misuse and adherence issues, 3M Drug Delivery Systems introduces the 3M Intelligent Control Inhaler, an intuitive, fully-integrated device that delivers accurate doses to patients, whilst providing on-screen instructions for use and feedback to the patient and healthcare provider via an app.
J&J, GSK in Legal Dust-Up Over Flonase Allergy Claims